Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.

Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH.

PLoS One. 2012;7(10):e48366. doi: 10.1371/journal.pone.0048366. Epub 2012 Oct 31.

2.

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.

Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A.

Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.

PMID:
21606975
3.

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C.

Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, Tajima A, Shimotohno K.

BMC Med Genomics. 2010 Oct 22;3:48. doi: 10.1186/1755-8794-3-48.

4.

Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.

Yamaura Y, Tatsumi N, Takagi S, Tokumitsu S, Fukami T, Tajiri K, Minemura M, Yokoi T, Nakajima M.

Clin Biochem. 2017 Dec;50(18):1034-1039. doi: 10.1016/j.clinbiochem.2017.08.010. Epub 2017 Aug 18.

PMID:
28823616
5.

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L.

PLoS One. 2011;6(8):e23937. doi: 10.1371/journal.pone.0023937. Epub 2011 Aug 23.

6.

Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, Baranova A, Chandhoke V, Younossi ZM.

Aliment Pharmacol Ther. 2010 Aug;32(3):487-97. doi: 10.1111/j.1365-2036.2010.04366.x. Epub 2010 May 22.

7.

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.

Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.

Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.

PMID:
18609175
8.

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.

Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, Welker M, Shi Y, Peveling-Oberhag J, Polta A, von Wagner M, Radeke HH, Sarrazin C, Trojan J, Zeuzem S, Kronenberger B, Piiper A.

PLoS One. 2011;6(10):e26971. doi: 10.1371/journal.pone.0026971. Epub 2011 Oct 31.

9.

Circulating microRNAs in hepatitis B virus-infected patients.

Ji F, Yang B, Peng X, Ding H, You H, Tien P.

J Viral Hepat. 2011 Jul;18(7):e242-51. doi: 10.1111/j.1365-2893.2011.01443.x. Epub 2011 Mar 7.

PMID:
21692939
10.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
11.

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.

Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S.

Hepatology. 2009 Apr;49(4):1098-112. doi: 10.1002/hep.22749.

PMID:
19173277
12.

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML.

Leukemia. 2012 Jul;26(7):1654-62. doi: 10.1038/leu.2012.29. Epub 2012 Feb 6.

PMID:
22307176
13.

Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.

Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC.

PLoS One. 2012;7(3):e33608. doi: 10.1371/journal.pone.0033608. Epub 2012 Mar 14.

14.

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.

Gut. 2011 Oct;60(10):1394-402. doi: 10.1136/gut.2010.222844. Epub 2011 Jan 26.

PMID:
21270117
15.

Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y, Zhang CY.

Clin Chem. 2012 Mar;58(3):610-8. doi: 10.1373/clinchem.2011.172767. Epub 2011 Dec 22.

16.

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K.

Cancer Res. 2010 Dec 1;70(23):9798-807. doi: 10.1158/0008-5472.CAN-10-1001. Epub 2010 Nov 23. Erratum in: Cancer Res. 2011 Mar 1;71(5):2022.

17.

Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.

Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2422-5.

PMID:
10522010
18.

Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.

Yamaura Y, Nakajima M, Takagi S, Fukami T, Tsuneyama K, Yokoi T.

PLoS One. 2012;7(2):e30250. doi: 10.1371/journal.pone.0030250. Epub 2012 Feb 17.

19.

Distribution profiling of circulating microRNAs in serum.

Ashby J, Flack K, Jimenez LA, Duan Y, Khatib AK, Somlo G, Wang SE, Cui X, Zhong W.

Anal Chem. 2014 Sep 16;86(18):9343-9. doi: 10.1021/ac5028929. Epub 2014 Sep 5.

20.

MicroRNA modulation in complex regional pain syndrome.

Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE, Schwartzman RJ, Ajit SK.

J Transl Med. 2011 Nov 10;9:195. doi: 10.1186/1479-5876-9-195.

Supplemental Content

Support Center